PolarityTE, Inc. (NASDAQ:PTE)
About the company
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|Activision Blizzard, Inc.||ATVI||62740.44||6452.00||4.81||40.23||24.19|
|Electronic Arts, Inc.||EA||41370.80||5537.00||5.43||13.62||54.89|
|Take-Two Interactive Software, Inc.||TTWO||17545.74||3089.00||6.90||43.48||13.09|
|Thor Industries, Inc.||THO||5601.75||8155.00||2.69||28.45||2.40|
|Fox Factory Holding Corp.||FOXF||3249.09||774.00||8.03||39.11||10.75|
|Acushnet Holdings Corp.||GOLF||2570.25||1656.00||2.88||27.20||5.74|
|Winnebago Industries, Inc.||WGO||2006.73||2148.00||2.61||38.73||2.37|
|Callaway Golf Co.||ELY||1634.88||1627.00||2.11||27.47||3.67|
|Sturm, Ruger & Co., Inc.||RGR||1330.38||420.00||4.34||37.90||8.24|
|Johnson Outdoors, Inc.||JOUT||867.20||571.00||2.52||16.55||9.24|
|Vista Outdoor, Inc.||VSTO||850.28||1756.00||1.92||-5.47||-8.83|
|Marine Products Corp.||MPX||472.26||268.00||6.12||19.03||9.10|
|Mastercraft Boat Holdings, Inc.||MCFT||352.26||435.00||6.82||-11.10||-7.19|
|Super League Gaming, Inc.||SLGG||22.23||1.00||2.87||-1.36||None|
|JAKKS Pacific, Inc.||JAKK||21.54||594.00||-2.33||-0.54||-6.52|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
PolarityTE, Inc. (Nasdaq: PTE) reports the recent publication of two peer-reviewed manuscripts involving the application of SkinTE in a pilot study of diabetic foot ulcers and a 15-patient case ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.
Mann has more than 20 years of experience in the financial and biotechnology industries. Most recently, he served as CFO at PolarityTE, Inc., a biotechnology and regenerative biomaterials company.
Mr. Mann has over 20 years of experience in the financial and biotechnology industries. Most recently, he served as CFO at PolarityTE, Inc., a biotechnology and regenerative biomaterials company, ...
PolarityTE, Inc. (Nasdaq: PTE) reports the recent publication of two peer-reviewed manuscripts involving the application of SkinTE in a pilot study of diabetic foot ulcers and a 15-patient case series ...
Chief Financial Officer 1,283 Disposition at $1.05 per share. 1,347 ...